期刊
JAMA ONCOLOGY
卷 8, 期 3, 页码 335-336出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2021.6854
关键词
-
类别
This viewpoint compares the US FDA's accelerated approval pathway for drugs and biologics with similar programs developed by other international regulatory health authorities.
This Viewpoint compares the US Food and Drug Administration's accelerated approval pathway for drugs and biologics with similar programs developed by other international regulatory health authorities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据